Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 EBITDA Margin % is 40.69% as of Mar. 2026, which is 0% below its 10-year median of 40.80. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 93.98% on this metric.
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Gaudium IVF And Women Health EBITDA Margin % Related Terms
Gaudium IVF And Women Health EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaudium IVF And Women Health EBITDA Margin % Chart
NSE:GAUDIUMIVF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a EBITDA Margin % of 40.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gaudium IVF And Women Health and its competitors. This is near median its historical median of 40.80. Over the past decade, Gaudium IVF And Women Health's EBITDA Margin % has ranged from 34.64 to 45.41. According to the industry distribution chart, Gaudium IVF And Women Health ranks #40 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 6%.
Is Gaudium IVF And Women Health's EBITDA Margin % too high?
Gaudium IVF And Women Health's current EBITDA Margin % of 40.69% is near median its 10-year median of 40.80. Over the past 10 years, this metric has ranged from a low of 34.64 to a high of 45.41. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Gaudium IVF And Women Health's value of 40.69% is 297.4% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #40 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #40 out of 665 companies for EBITDA Margin %. This places Gaudium IVF And Women Health in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Gaudium IVF And Women Health's value of 40.69% is 297.4% above this benchmark. Historically, Gaudium IVF And Women Health's own EBITDA Margin % has ranged from 34.64 to 45.41 over the past decade. While the company's 10-year median is 40.80 vs. the industry median of 10.24, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current EBITDA Margin % of 40.69% is 297.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current EBITDA Margin % is 40.69%, which is near median its own 10-year median of 40.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current EBITDA Margin % of 40.69%. The current EBITDA Margin % is 40.69%, which is near median its 10-year median of 40.80 and 297.4% above the Healthcare Providers & Services industry median of 10.24. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current EBITDA Margin % is 40.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
